Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease - PubMed (original) (raw)
Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease
P Desreumaux et al. Gastroenterology. 1997 Jul.
Abstract
Background & aims: Chronic intestinal lesions of patients with Crohn's disease (CD) are associated with a T helper (Th) 1-type cytokine profile, including high levels of interleukin 2 (IL-2) and interferon gamma (IFN-gamma). However, the mechanisms involved in the pathogenesis of the early mucosal lesions are poorly known. The aim of this study was to examine the pattern of Th1- and Th2-type (IL-4, IL-5, and IL-13) cytokines in the early ileal lesions occurring in patients with CD 3 months after ileal resection and ileocolonic anastomosis. Cytokines were also examined in the chronic ileal lesions to look for cytokine patterns related to disease progression.
Methods: Ileal biopsy specimens were obtained from 17 patients with CD and 11 controls. Mucosal IL-2, IFN-gamma, IL-4, IL-5, and IL-13 messenger RNA (mRNA) was evaluated by competitive reverse-transcription polymerase chain reaction.
Results: The early ileal lesions of patients with CD were associated with a significant increase of IL-4 mRNA and a decrease of IFN-gamma mRNA compared with the normal mucosa of patients with CD or controls. A Th1-type pattern was observed in the chronic ileal lesions.
Conclusions: Divergent cytokine patterns are observed during different clinical stages of CD. These observations need to be considered in the development of newer specific therapeutic agents to prevent CD recurrences.
Similar articles
- Enhanced production of IL-8 in chronic but not in early ileal lesions of Crohn's disease (CD).
Brandt E, Colombel JF, Ectors N, Gambiez L, Emilie D, Geboes K, Capron M, Desreumaux P. Brandt E, et al. Clin Exp Immunol. 2000 Nov;122(2):180-5. doi: 10.1046/j.1365-2249.2000.01364.x. Clin Exp Immunol. 2000. PMID: 11091272 Free PMC article. - Increased expression of interleukin-32 in the inflamed ileum of ankylosing spondylitis patients.
Ciccia F, Rizzo A, Accardo-Palumbo A, Giardina A, Bombardieri M, Guggino G, Taverna S, Leo GD, Alessandro R, Triolo G. Ciccia F, et al. Rheumatology (Oxford). 2012 Nov;51(11):1966-72. doi: 10.1093/rheumatology/kes170. Epub 2012 Jul 30. Rheumatology (Oxford). 2012. PMID: 22847681 - Proinflammatory effects of TH2 cytokines in a murine model of chronic small intestinal inflammation.
Bamias G, Martin C, Mishina M, Ross WG, Rivera-Nieves J, Marini M, Cominelli F. Bamias G, et al. Gastroenterology. 2005 Mar;128(3):654-66. doi: 10.1053/j.gastro.2004.11.053. Gastroenterology. 2005. PMID: 15765401 - Should We Divide Crohn's Disease Into Ileum-Dominant and Isolated Colonic Diseases?
Dulai PS, Singh S, Vande Casteele N, Boland BS, Rivera-Nieves J, Ernst PB, Eckmann L, Barrett KE, Chang JT, Sandborn WJ. Dulai PS, et al. Clin Gastroenterol Hepatol. 2019 Dec;17(13):2634-2643. doi: 10.1016/j.cgh.2019.04.040. Epub 2019 Apr 19. Clin Gastroenterol Hepatol. 2019. PMID: 31009791 Free PMC article. Review. - Algorithmic Approach to Inflammatory Disorders of Ileum.
Moradi A, Mokhtarpour A, Yazdani A, Kianersi K, Bahari Khasraghi L. Moradi A, et al. Iran J Pathol. 2022 Fall;17(4):381-394. doi: 10.30699/IJP.2022.539357.2736. Epub 2022 Sep 10. Iran J Pathol. 2022. PMID: 36532649 Free PMC article. Review.
Cited by
- Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation.
Philippe D, Dubuquoy L, Groux H, Brun V, Chuoï-Mariot MT, Gaveriaux-Ruff C, Colombel JF, Kieffer BL, Desreumaux P. Philippe D, et al. J Clin Invest. 2003 May;111(9):1329-38. doi: 10.1172/JCI16750. J Clin Invest. 2003. PMID: 12727924 Free PMC article. - Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease.
Schreiber S, Rosenstiel P, Hampe J, Nikolaus S, Groessner B, Schottelius A, Kühbacher T, Hämling J, Fölsch UR, Seegert D. Schreiber S, et al. Gut. 2002 Sep;51(3):379-85. doi: 10.1136/gut.51.3.379. Gut. 2002. PMID: 12171960 Free PMC article. - Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease.
Kugathasan S, Saubermann LJ, Smith L, Kou D, Itoh J, Binion DG, Levine AD, Blumberg RS, Fiocchi C. Kugathasan S, et al. Gut. 2007 Dec;56(12):1696-705. doi: 10.1136/gut.2006.116467. Epub 2007 Aug 6. Gut. 2007. PMID: 17682002 Free PMC article. - Cytokine/chemokine transcript profiles reflect mucosal inflammation in Crohn's disease.
Stallmach A, Giese T, Schmidt C, Ludwig B, Mueller-Molaian I, Meuer SC. Stallmach A, et al. Int J Colorectal Dis. 2004 Jul;19(4):308-15. doi: 10.1007/s00384-003-0554-4. Epub 2003 Nov 7. Int J Colorectal Dis. 2004. PMID: 14605835 - Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease.
Louis E, Ribbens C, Godon A, Franchimont D, De Groote D, Hardy N, Boniver J, Belaiche J, Malaise M. Louis E, et al. Clin Exp Immunol. 2000 May;120(2):241-6. doi: 10.1046/j.1365-2249.2000.01227.x. Clin Exp Immunol. 2000. PMID: 10792371 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical